Mount Sinai Prime — New York, New York

Mount Sinai Prime is a clinical research site located in New York, New York, United States 10029.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Mount Sinai Prime has participated in 2 clinical trials.

Therapeutic areas: Metastatic Head and Neck Squamous Cell Carcinoma, Advanced Malignancies, Recurrent Head and Neck Squamous Cell Carcinoma.

Sponsors: Incyte Biosciences International Sàrl, BeiGene.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Prime?

Mount Sinai Prime has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Prime conducted?

Mount Sinai Prime has 2 clinical trials on record. Their work covers Metastatic Head and Neck Squamous Cell Carcinoma, Advanced Malignancies, Recurrent Head and Neck Squamous Cell Carcinoma.

Is Mount Sinai Prime accredited by Crixeo Health?

Mount Sinai Prime has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Prime?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.